FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new compounds of formula I:
or pharmaceutically acceptable salts thereof, wherein the values R1, R3, and R4 are specified in cl. one of the patent claim.
EFFECT: compounds inhibit the HCV replication that makes them applicable for preparing a pharmaceutical composition and a drug preparation for HCV infection.
16 cl, 3 tbl, 10 dwg, 30 ex
Title | Year | Author | Number |
---|---|---|---|
2-SUBSTITUTED BENZIMIDAZOLES | 2006 |
|
RU2441866C2 |
6,7,8,9-SUBSTITUTED 1-PHENYL-1,5-DIHYDROPYRIDO (3,2-b) INDOLE-2-ONES EFFECTIVE AS ANTIINFECTIOUS PHARMACEUTICAL AGENTS | 2005 |
|
RU2377243C2 |
1,5,6-SUBSTITUTED 2-OXO-3-CYANO-1,6A-DIAZATETRAHYDROFLUORANTHENES | 2006 |
|
RU2389730C2 |
CONDENSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2700004C1 |
DERIVATIVES OF INDOLE AS INHIBITORS OF XA FACTOR | 1998 |
|
RU2225397C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
PYRIDO [2,3-d] PYRIMIDINES, USEFUL AS HCV INHIBITORS AND SYNTHESIS METHODS THEREOF | 2006 |
|
RU2444522C2 |
1,3-DIHYDROBENZIMIDAZOL-2-YLIDEN AMINES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | 2006 |
|
RU2410382C2 |
HIV-INHIBITING 5-CARBO- OR HETEROCYCLIC SUBSTITUTED PYRIMIDINES | 2005 |
|
RU2403244C2 |
DIHYDROBENZOPYRANE DERIVATIVES WITH VASOCONSTRICTIVE EFFECT, INTERMEDIATE COMPOUNDS, PREPARATION METHODS, PHARMACEUTICAL COMPOSITION, METHOD OF PREPARING THEREOF | 1994 |
|
RU2129556C1 |
Authors
Dates
2013-06-27—Published
2008-12-23—Filed